Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Eckard Kujath has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12756214

SUBSTITUTED 2-(CHROMAN-6-YLOXY)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/427, C07D 487/04, C07D 471/04, C07D 417/14, C07D 417/12, A61P 9/10, A61P 9/06
Applicant:
Sanofi, S.A.
Agent:
Paula De Souza, Sanofi
Agent:
Eckard Kujath, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12759725

N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/4985, C07D 487/04, A61P 19/02
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
The patent has been granted
EP14710222

SUBSTITUTED CHROMAN-6-YLOXY-CYCLOALKANES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61P 9/00, A61K 31/353, C07F 9/09, C07D 417/14, C07D 417/12, C07D 413/12, C07D 409/12, C07D 407/14, C07D 407/12, C07D 405/12, C07D 311/60
Applicant:
Sanofi, S.A.
Agent:
Paula De Souza, Sanofi
Agent:
Eckard Kujath, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP14711467

N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61P 19/02, A61P 9/00, A61K 31/52, A61K 31/437, C07D 487/04, C07D 471/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED

Please Sign in to use this feature